BioStock: CombiGene’s new CEO talks about his visions for the company

Jan Nilsson, CEO of gene therapy company CombiGene since 2016, has left his post and last Friday Peter Ekolind, former COO, took over as the new CEO. Ekolind, previously CEO of Getinge Sweden, tells BioStock that CombiGene is in a dynamic and exciting phase with the potential to achieve several milestones in the future.  

Read the full interview with Peter Ekolind at biostock.se:

https://www.biostock.se/en/2023/09/combigenes-new-ceo-talks-about-his-visions-for-the-company/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/